Utah Medical Marijuana Sales Near $17 Million in May, Top $84 Million in 2026 as Patient Count Hits 114,000
- Utah’s medical marijuana program generated nearly $17 million in sales in May 2026, with a total of approximately $84 million in sales so far this year.
- Patient enrollment increased to 114,090 active cardholders in May, up by 888 from April, with the largest patient demographic being ages 31 to 40 (26.06%).
- Persistent pain remains the most common qualifying condition, affecting 99,595 patients, followed by PTSD (5,548) and nausea (2,430).
- Top-selling products included cartridges and vape pens ($8.23 million), flower ($5.59 million), and infused edibles ($2.89 million), with strong patient purchasing activity sustained over recent months.
Utah’s medical marijuana generated nearly $17 million in sales in May, according to a new report released by the Department of Health & Human Services.
The state’s May 2026 report shows Utah had 114,090 patients with active medical marijuana cards as of the end of the month, up from 113,202 in April. That’s an increase of 888 patients in one month.
The program also includes 1,024 registered recommending medical providers, 167 paper-only recommending medical providers, 937 processor and cultivator agents, 969 pharmacy agents, 445 courier agents and 97 pharmacy medical providers.
Patient demographics remained largely in line with prior months. Those ages 31 to 40 continue to make up the largest share of patients at 26.06%, followed by those 41 to 50 at 22.37% and those 21 to 30 at 21.92%. Patients ages 51 to 64 account for 18.46%, while those over 65 make up 11.12%.
Persistent pain remains by far the most common qualifying condition, with 99,595 patients listing it. PTSD was next at 5,548 patients, followed by nausea at 2,430, cancer at 2,101, autism at 778, epilepsy at 727, MS at 725 and Crohn’s disease at 566.
Medical marijuana sales totaled $16,952,200 in May, up slightly from $16,911,700 in April. With May included, Utah’s 2026 medical marijuana sales now total roughly $84 million.
Cartridges and vape pens remained the state’s top-selling product category, generating $8,232,000 in May sales. Flower followed at $5,590,900, while infused edibles brought in $2,887,000. Infused non-edible products accounted for $114,100, with non-medicated items such as pens, vaporizers, devices, grinders, batteries and cases adding $128,200.
Patient activity remained strong, with 63,023 patients making at least one purchase over the past 30 days. Over the past 90 days, 88,129 patients made at least one purchase, while 43,782 made four or more purchases.
On the production side, licensed medical marijuana pharmacies received 183,079 cartridges and pens from processors in May, along with 128,843 units of flower and 115,165 infused edible products.
Cultivators harvested 10,260 medical marijuana plants in May across 229 planting batches, producing nearly 8.9 million grams of wet cannabis biomass.
The May report shows continued growth for Utah’s medical marijuana program, with patient enrollment reaching a new high and sales remaining near $17 million for the second straight month.